Want to know what's happening next in healthcare?

MedCityNews is the leading online news source for the business of innovation in healthcare.

“MedCity is invaluable among the many sources of industry reporting because the team endeavor to bring the truly new, and innovative opportunities and developments to light.”

Ken Kirby, President, Transdermal Delivery Solutions Corp

Sign up for our daily newsletter

Forest Laboratories submits Cariprazine drug application

2:17 am by | 0 Comments

BUDAPEST (Reuters) - Forest Laboratories has recently submitted a new drug application to the U.S. Food and Drug Administration (FDA) for antipsychotic drug Cariprazine, its Hungarian partner Richter said in a statement on Wednesday.

Cariprazine was discovered by Richter and is licensed to Forest Laboratories Inc. in the U.S. and Canada.

Richter said Forest's application to the FDA was submitted for the treatment of both schizophrenia and manic or mixed episodes associated with bipolar I disorder.

(Reporting by Gergely Szakacs; Editing by David Goodman)


Copyright 2014 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Hear the latest news first

Get our daily newsletter or follow us.